SAN JUAN CAPISTRANO, Calif.–(BUSINESS WIRE)–<a href="https://twitter.com/hashtag/DME?src=hash" target="_blank">#DME</a>–Allegro Ophthalmics announced that the results of its US Phase 2 study evaluating risuteganib for…
Author: Business Wire
Compulink Previews New User Interface for its Ophthalmology SMART EHR at ASRS 2019
NEWBURY PARK, Calif.–(BUSINESS WIRE)–Compulink previews new user interface for its Ophthalmology SMART EHR at ASRS 2019.
Omeros’ OMIDRIA® Receives Product-Specific J-Code from CMS
SEATTLE–(BUSINESS WIRE)–Omeros Corporation today announced that the Centers for Medicare and Medicaid Services (CMS) confirmed its preliminary decision to assign a permanent product-specific Healthcare Common Procedure Coding System (HCPCS) J-code fo…
United States Allergic Conjunctivitis Market & Competitive Landscape: 2014-2019 & 2024 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “US Allergic Conjunctivitis Market and Competitive Landscape – 2019” report has been added to ResearchAndMarkets.com’s offering. The latest research provides comprehensive insights into Allergic Conjunctivitis pipeline products, Allergic Conjunctivitis epidemiology, Allergic Conjunctivitis market valuations and forecast, Allergic Conjunctivitis drugs sales and competitive landscape in the US. The research is classified into seven sections – Allergic Conjunctivitis t
Inland Empire Health Plan Multi-county eConsult Initiative with Safety Net Connect Improves Specialty Care for Southern California Residents
NEWPORT BEACH, Calif.–(BUSINESS WIRE)–<a href="https://twitter.com/hashtag/connectedhealth?src=hash" target="_blank">#connectedhealth</a>–Multi-county initiative using Converge eConsult technology improves specialty c…
SeniorWell Expands Service to Iowa and Virginia
CHICAGO–(BUSINESS WIRE)–SeniorWell announces its expansion into Iowa and Virginia. The company’s move into Virginia marks SeniorWell’s first presence in the Southeast.
PolyActiva Completes Recruitment in Key Phase I Glaucoma Implant Safety Study. Six-month Treatment Period Demonstrated.
CHICAGO–(BUSINESS WIRE)–PolyActiva Pty Ltd, a clinical-stage biotechnology company and leader in ocular drug delivery, has completed patient enrolment for its Phase I clinical trial to study safety and tolerability of its biodegradable, slow-release …
IVERIC bio Announces Successful Advancement of LCA10 Minigene Program and Expansion of Orphan Gene Therapy Portfolio with USH2A-Related Inherited Retinal Diseases Program
NEW YORK–(BUSINESS WIRE)–IVERIC bio announced that the Company has entered into an exclusive global license agreement with the University of Massachusetts Medical School.
Top 5 Vendors in the Ophthalmic Lens Market from 2019 to 2023 | Technavio
LONDON–(BUSINESS WIRE)–<a href="https://twitter.com/hashtag/HealthcareDevices?src=hash" target="_blank">#HealthcareDevices</a>–The global ophthalmic lens market is highly competitive with major vendors competing based…
Visioneering Wins Award of Excellence for Its NaturalVue® Multifocal 1 Day Contact Lenses at Australia’s Largest Eyecare Event
MELBOURNE, Australia–(BUSINESS WIRE)–US-based medical device company Visioneering Technologies Inc. (ASX: VTI) (‘Visioneering’ or ‘The Company’) is pleased to announce that it has received the Award of Excellence for its innovative NaturalVue® (etafi…
Ocuphire Pharma Raises Over $5 Million to Complete Multiple Late Phase 2 Clinical Trials
FARMINGTON HILLS, Mich.–(BUSINESS WIRE)–Ocuphire Pharma Raises First Round of Over $5 Million to Complete Multiple Late Phase 2 Ophthalmic Clinical Trials
Glaukos Announces Global Licensing Agreement With Intratus, Inc.
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, announced today that …
GEHA Announces Exclusive Multi-year Partnership With Kansas City Chiefs and Patrick Mahomes
LEE’S SUMMIT, Mo.–(BUSINESS WIRE)–Government Employees Health Association, Inc. (GEHA) today announces a new partnership with the Kansas City Chiefs and Patrick Mahomes, reigning NFL MVP, Chiefs quarterback and new GEHA Official Brand Partner. “GEHA …
United States Wet Age-Related Macular Degeneration Market Report 2019: The Pipeline, Epidemiology, Market Valuations, Drugs (Sales & Market Share), and Competitive Landscape Through 2014-2024 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “US Wet Age-Related Macular Degeneration Market and Competitive Landscape – 2019” report has been added to ResearchAndMarkets.com’s offering. This report provides comprehensive insights into Wet Age-Related Macular Degeneration pipeline products, Wet Age-Related Macular Degeneration epidemiology, Wet Age-Related Macular Degeneration market valuations and forecast, Wet Age-Related Macular Degeneration drugs sales and competitive landscape in the US. The research is c
United States Eyewear Market: Size, Trends Analysis, and Forecasts (2019-2024) – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “United States Eyewear Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2024” report has been added to ResearchAndMarkets.com’s offering. The country research report on United States eyewear market is a customer intelligence and competitive study of the United States market. Moreover, the report provides deep insights into demand forecasts, market trends, and, micro and macro indicators in the United States market. Also, factors that are driving a
Minimally Invasive Glaucoma Surgery (MIGS) Devices: Global Market to Record a CAGR of 24.6% During 2019-2025 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Minimally Invasive Glaucoma Surgery Devices Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025” report has been added to ResearchAndMarkets.com’s offering. The report predicts the global minimally invasive glaucoma surgery devices market to grow with a CAGR of 24.6% over the forecast period from 2019-2025. The report on the global minimally invasive glaucoma surgery devices market provides qualitative and quantitative analysis for the p
Global Photochromic Lens Market, Competition, Forecast & Opportunities 2024 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Photochromic Lens Market By Material, By Technology (In-Mass & Imbibing & Trans Bonding), By Application (Corrective & Preventive), By Distribution Channel, By Region, Competition, Forecast & Opportunities 2024” report has been added to ResearchAndMarkets.com’s offering. The global photochromic lens market is projected to reach $ 7.7 billion by 2024 from around $ 4.8 billion in 2018, exhibiting a CAGR of 8.3% during forecast period, owing to
Sun Pharma Introduces Access Program for Patients Prescribed XELPROS in the U.S.
PRINCETON, N.J.–(BUSINESS WIRE)–<a href="https://twitter.com/hashtag/glaucoma?src=hash" target="_blank">#glaucoma</a>–Sun Pharma Introduces Access Program for Patients Prescribed XELPROS in the U.S.
Eye Surgery Associates Enters Strategic Partnership With Eyecare Services Partners
DALLAS–(BUSINESS WIRE)–Eye Surgery Associates (“ESA”), one of the leading comprehensive eye care providers in South Florida, has entered into a strategic partnership with Eyecare Services Partners Management, LLC (“ESP”), the leading national provide…
Detailed Review of Tebentafusp (IMCgp100) in Metastatic Uveal Melanoma Published in Issue of Cancers
OXFORD, England & CONSHOHOCKEN, Pa. & ROCKVILLE, Md–(BUSINESS WIRE)–Immunocore Limited, a leading T Cell Receptor (TCR) biotechnology company, today announce the publication of “Tebentafusp: T Cell Redirection for the Treatment of Metastatic …